

Engineering the future of molecular synthesis
We program specific microalgae strains to synthesize clinical-grade compounds. Join a team of biochemists and engineers operating at thermodynamic limits.
Designed for breakthrough science
We provide the clinical-grade platforms and intellectual autonomy required to translate photosynthetic efficiency into high-purity bioactive compounds.
Next-gen facilities
Metabolic autonomy
Equity & growth
Work with custom-built photobioreactors and high-resolution mass spectrometers in our sterile Basel facility.
Direct your own research pathways within our closed-loop carbon capture and molecular synthesis programs.
Secure venture-backed equity, competitive clinical-grade compensation, and comprehensive Swiss healthcare benefits.
Join our research cohorts
Senior Metabolic Engineer - Strain Optimization
Optimize proprietary marine microalgae strains to maximize biosynthesis of high-purity oncology compounds.
Photobioreactor Scale-Up Specialist
Design and automate closed-loop sterile photobioreactors, scaling metabolic yields from bench to industrial outputs.
Enterprise Sustainability Director
Bridge the gap between our carbon-negative yields and Fortune 500 enterprise carbon capture agreements.
Begin your inquiry
Submit your CV or research proposal directly to our talent acquisition team in Zurich.
Valgogenix Biotech
Precision microalgae synthesis for pharmaceutical compounds and enterprise carbon capture.
Platform
Overview
About
Science
Pipeline
Sustainability
Careers
Inquiries
investors@valgogenix.com
Zurich, Switzerland
Clinical Facility: Basel
© 2026 Valgogenix Biotech-Clinical-grade synthesis platforms.
MOLECULAR PURITY - CARBON-NEGATIVE YIELD
